Belatacept Pharmacokinetic Trial in Renal Transplantation
| Status: | Completed |
|---|---|
| Conditions: | Renal Impairment / Chronic Kidney Disease |
| Therapuetic Areas: | Nephrology / Urology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 10/14/2017 |
| Start Date: | March 2008 |
| End Date: | September 2012 |
An Open-label Pharmacokinetic Study in De Novo Renal Transplant Subjects Receiving a Belatacept Based Immunosuppressant Regimen
The purpose of this study is to assess the pharmacokinetics and safety of belatacept in de
novo renal transplant subjects treated with belatacept-based immunosuppressant medication
novo renal transplant subjects treated with belatacept-based immunosuppressant medication
Inclusion Criteria:
- Recipient of a living or deceased donor kidney
- First or second transplant
- Men and women, including women of childbearing potential, 18 years and older
Exclusion Criteria:
- Panel reactive antibodies ≥ 30%
- Significant infection
We found this trial at
3
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials